首页> 外国专利> KP1 Novel Klebsiella genus bacteria specific bacteriophage KP1 and antibacterial composition comprising the same

KP1 Novel Klebsiella genus bacteria specific bacteriophage KP1 and antibacterial composition comprising the same

机译:KP1新型克雷伯氏菌属细菌特异性噬菌体KP1和包含其的抗菌组合物

摘要

The present invention relates to a novel bacteriophage KP1 having killing activity specific to a bacterium belonging to the genus Klebsiella, particularly an extended-spectrum beta-lactamase ( Klebsiella ) bacterium, a Klebsiella bacterium comprising the bacteriophage A method for preventing or treating an infectious disease caused by Klebsiella, which comprises the step of administering to a subject a pharmaceutical composition, antibiotic composition, feed additive composition, feed, disinfectant or detergent for preventing or treating infectious diseases caused by infectious diseases . The method for preventing or treating infectious diseases caused by Klebsiella spp. Using the bacteriophage KP1 of the present invention is more specific than the conventional antibiotics such as Klebsiella spp., Especially ESBL-Klebsiella spp. And the bacteriophage KP1 has an advantage of being excellent in physicochemical stimulation by exhibiting excellent lytic activity by infection with Klebsiella spp. In addition, since the bacteriophage KP1 of the present invention is not infected with any host other than a bacterium such as a human, an animal, or a plant, it has an advantage of being able to solve problems of antibiotic resistant bacteria caused by abuse of antibiotics, have. Accordingly, the bacteriophage KP1 of the present invention can be used in various fields in the field of preventing or treating infectious diseases caused by Klebsiella spp., Antibiotic composition, composition for feed addition, feed, disinfectant, or detergent.
机译:本发明涉及具有对属于克雷伯氏菌属的细菌,特别是广谱β-内酰胺酶(Klebsiella )细菌具有特异性的杀灭活性的新型噬菌体KP1,包括该噬菌体的克雷伯氏菌A方法用于预防或治疗由克雷伯菌引起的感染性疾病的方法,其包括向受试者施用用于预防或治疗由感染性疾病引起的感染性疾病的药物组合物,抗生素组合物,饲料添加剂组合物,饲料,消毒剂或去污剂的步骤。预防或治疗由克雷伯菌属引起的传染病的方法。使用本发明的噬菌体KP1比常规抗生素,例如克雷伯氏菌属,特别是ESBL-克雷伯氏菌属,更具特异性。并且,噬菌体KP1具有通过感染克雷伯菌属而表现出优异的裂解活性而在物理化学刺激方面优异的优点。另外,由于本发明的噬菌体KP1不被诸如人,动物或植物的细菌以外的任何宿主感染,因此具有能够解决由滥用引起的抗生素抗性细菌的问题的优点。抗生素。因此,本发明的噬菌体KP1可用于预防或治疗由克雷伯菌属引起的传染病,抗生素组合物,饲料添加组合物,饲料,消毒剂或去污剂的各个领域。

著录项

  • 公开/公告号KR101993122B1

    专利类型

  • 公开/公告日2019-06-26

    原文格式PDF

  • 申请/专利权人 주식회사 옵티팜;

    申请/专利号KR20170169376

  • 申请日2017-12-11

  • 分类号C12N7;A01N63;A23K10/16;A23K20/195;A23L3/3571;A61K35/76;C11D3/48;

  • 国家 KR

  • 入库时间 2022-08-21 11:48:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号